PROTAGONIST THERAPEUTICS, INC. logo

PROTAGONIST THERAPEUTICS, INC.

8 Marks
Corp.
First Filed:Mar 2, 2018Latest Filed:Dec 18, 2023Address:7707 Gateway Blvd. Suite 210, Newark, CA 94560, US

Portfolio Overview

Registered
1(13%)
Pending
6(75%)
Dead
1(13%)
Previous
1

Top Classes

Class 42
Software, IT Services & Scientific Research
8(100%)
Class 5
Pharmaceuticals
6(75%)
Class 44
Medical, beauty and agricultural services
6(75%)

TTAB Proceedings

No litigation activity

Top Firms

Christensen O'Connor Johnson...(Dec 2023)
7
Troutman Pepper Locke LLP(Sep 2022)
1
Klauber & Jackson LLC(Mar 2018)
1

Trademark Portfolio

9 results

(current & previous marks)

Refine by Mark/Description🔽
Filed
Registered
Last Activity
PROTAGONIST THERAPEUTICS
PROTAGONIST THERAPEUTICS
Trademark
Combined
ITU
PENDING
Owner:
Serial:98319631
Filed:Dec 18, 2023
Classes:5, 42, 44
Goods & Services
Pharmaceutical preparations for the treatment of oncological, hematological, inflammatory and autoimmune disorders, rare and orphan disorders, endocrine disorders; Providing online healthcare and medical information to patients and healthcare providers relating to oncological, hematological, inflammatory and autoimmune disorders, rare and orphan disorders, endocrine disorders; "THERAPEUTICS"; Scientific and medical research relating to oncological, hematological, inflammatory and autoimmune disorders, rare and orphan disorders, endocrine disorders
PROTAGONIST THERAPEUTICS
PROTAGONIST THERAPEUTICS
Trademark
Combined
ITU
PENDING
Owner:
Serial:98319352
Filed:Dec 18, 2023
Classes:5, 42, 44
Goods & Services
Pharmaceutical preparations for the treatment of oncological, hematological, inflammatory and autoimmune disorders, rare and orphan disorders, endocrine disorders; Providing online healthcare and medical information to patients and healthcare providers relating to oncological, hematological, inflammatory and autoimmune disorders, rare and orphan disorders, endocrine disorders; "THERAPEUTICS"; Scientific and medical research relating to oncological, hematological, inflammatory and autoimmune disorders, rare and orphan disorders, endocrine disorders
PROTAGONIST THERAPEUTICS
PROTAGONIST THERAPEUTICS
Trademark
Word
ITU
PENDING
Owner:
Serial:98319346
Filed:Dec 18, 2023
Classes:5, 42, 44
Goods & Services
Pharmaceutical preparations for the treatment of oncological, hematological, inflammatory and autoimmune disorders, rare and orphan disorders, endocrine disorders; Providing online healthcare and medical information to patients and healthcare providers relating to oncological, hematological, inflammatory and autoimmune disorders, rare and orphan disorders, endocrine disorders; "THERAPEUTICS"; Scientific and medical research relating to oncological, hematological, inflammatory and autoimmune disorders, rare and orphan disorders, endocrine disorders
PROTAGONIST THERAPEUTICS
PROTAGONIST THERAPEUTICS
Trademark
Word
ITU
PENDING
Owner:
Serial:97822178
Filed:Mar 3, 2023
Classes:5, 42, 44
Goods & Services
Pharmaceuticals for use in the treatment of cancer and blood diseases and disorders; pharmaceutical preparations for the treatment of inflammatory disorders; pharmaceutical preparations for the treatment of metabolic disorders; Providing healthcare information to healthcare professionals and patients relating to disease states and treatment options; Medical information services in the fields of pharmaceuticals, oncology, and blood diseases and disorders; "THERAPEUTICS"; Medical research and medical research information services in the fields of pharmaceuticals, oncology, and blood diseases and disorders; Scientific research, pharmaceutical research, medical research; technical consultation services in the field of research and product development for the treatment of immune mediated diseases, inflammatory diseases, oncological disorders and rare diseases; scientific consultation services in the fields of immune mediated diseases, inflammatory diseases, oncological disorders and rare diseases; product development services for others in the fields of immune mediated diseases, inflammatory diseases, oncological disorders and rare diseases; research and development of new products pertaining to the treatment of immune mediated diseases, inflammatory diseases, oncological and rare diseases
ZYTREDI
ZYTREDI
Trademark
Word
ITU
PENDING
Owner:
Serial:97777616
Filed:Feb 2, 2023
Classes:5, 42, 44
Goods & Services
Pharmaceuticals for use in the treatment of cancer and blood diseases and disorders; Providing healthcare information to healthcare professionals and patients relating to the disease state and treatment options; Medical information services in the fields of pharmaceuticals, oncology, and blood diseases and disorders; Medical research and medical research information services in the fields of pharmaceuticals, oncology, and blood diseases and disorders
MIMRELSA
MIMRELSA
Trademark
Word
ITU
PENDING
Owner:
Serial:97696650
Filed:Nov 29, 2022
Classes:5, 42, 44
Goods & Services
Pharmaceuticals for use in the treatment of cancer and blood diseases and disorders; Medical information services in the fields of pharmaceuticals, oncology, and blood diseases and disorders; Medical research and medical research information services in the fields of pharmaceuticals, oncology, and blood diseases and disorders
PROTAGONIST THERAPEUTICS
PROTAGONIST THERAPEUTICS
Service Mark
Combined
REGISTERED
Owner:
Serial:88450820
Filed:May 29, 2019
Classes:42
Registration:6142951
Registered:Sep 1, 2020
Goods & Services
Class 042: SCIENTIFIC RESEARCH, PHARMACEUTICAL RESEARCH, MEDICAL RESEARCH; TECHNICAL AND SCIENTIFIC CONSULTATION AND PRODUCT DEVELOPMENT SERVICES FOR OTHERS, IN THE FIELD OF IMMUNE MEDIATED DISEASES, INFLAMMATORY DISEASES, AND RARE DISEASES; RESEARCH AND DEVELOPMENT OF NEW PRODUCTS PERTAINING TO THE TREATMENT OF IMMUNE MEDIATED DISEASES, INFLAMMATORY DISEASES, AND RARE DISEASES, AND TO PHARMACEUTICALS; PROVIDING ON-LINE INFORMATION FOR MEDICAL RESEARCH PURPOSES, IN THE FIELDS OF IMMUNE MEDIATED DISEASES, INFLAMMATORY DISEASES, AND RARE DISEASES, TREATMENTS FOR IMMUNE MEDIATED DISEASES, INFLAMMATORY DISEASES, AND RARE DISEASES, AND PHARMACEUTICALS
87817994
87817994
Service Mark
Design
ABANDONED
Owner:
Serial:87817994
Filed:Mar 2, 2018
Classes:42
RELINIFY
RELINIFY
Trademark
Word
Previous
ITU
PENDING
Owner:
Serial:97589986
Filed:Sep 13, 2022
Classes:5, 42, 44
Goods & Services
Pharmaceuticals for use in the treatment of cancer and blood diseases and disorders; Medical information services in the fields of pharmaceuticals, oncology, and blood diseases and disorders; Medical research and medical research information services in the fields of pharmaceuticals, oncology, and blood diseases and disorders

Cookie Preferences

We use cookies (including Google Analytics) to improve our site and understand how visitors use it.

View our privacy policy